Alcohol
Volume 43, Issue 7 , Pages 499-508 , November 2009

Young Investigator Award Symposium

  • Katie Witkiewitz

      Affiliations

    • These authors contributed equally.
    • Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    • ,
  • Andrew Holmes

      Affiliations

    • These authors contributed equally.
    • Section on Behavioral Science and Genetics, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, MD, USA
    • ,
  • Lara A. Ray

      Affiliations

    • These authors contributed equally.
    • Department of Psychology, University of California Los Angeles (UCLA), Los Angeles, CA, USA
    • ,
  • James G. Murphy

      Affiliations

    • These authors contributed equally.
    • Department of Psychology, University of Memphis, Memphis, TN 38152, USA
    • ,
  • Heather N. Richardson

      Affiliations

    • These authors contributed equally.
    • Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA
    • Department of Psychology-Neuroscience, University of Massachusetts Amherst, Amherst, MA 01003, USA
    • ,
  • Yi-Chyan Chen

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
    • ,
  • Meghan E. McDevitt-Murphy

      Affiliations

    • Department of Psychology, University of Memphis, Memphis, TN 38152, USA
    • ,
  • Maureen T. Cruz

      Affiliations

    • Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA
    • ,
  • Marisa Roberto

      Affiliations

    • Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-858-784-7262; fax: +1-858-784-7405.

Received 16 January 2009 ,Revised 18 May 2009 ,Accepted 21 June 2009.

References 

  1. Adinoff B, Iranmanesh A, Veldhuis J, Fisher L. Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res. World. 1998;22:67–72
  2. Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S. Suppression of the HPA axis stress-response: implications for relapse. Alcohol. Clin. Exp. Res. 2005;29:1351–1355
  3. Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol. Clin. Exp. Res. 1997;21:613–619
  4. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2001;
  5. Baer J. Student factors: understanding individual variation in college drinking. J. Stud. Alcohol. 2002;(14 Suppl):40–53
  6. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat. Psychopharmacology (Berl.). 1991;103:227–232
  7. Becker HC, Lopez MF. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol. Clin. Exp. Res. 2004;28:1829–1838
  8. Belzung C. The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models. Behav. Pharmacol. 2001;12:451–460
  9. Boyce-Rustay JM, Holmes A. Functional roles of NMDA receptor NR2A and NR2B subunits in the acute intoxicating effects of ethanol in mice. Synapse. 2005;56:222–225
  10. Boyce-Rustay JM, Holmes A. Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl.). 2006;187:455–466
  11. Boyce-Rustay JM, Cameron HA, Holmes A. Chronic swim stress alters sensitivity to acute behavioral effects of ethanol in mice. Physiol. Behav. 2007;91:77–86
  12. Boyce-Rustay JM, Janos AL, Holmes A. Effects of chronic swim stress on EtOH-related behaviors in C57BL/6 J, DBA/2 J and BALB/cByJ mice. Behav. Brain Res. 2008;186:133–137
  13. Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, et al. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol. Clin. Exp. Res. 2006;30:938–946
  14. Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, et al. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J. Stud. Alcohol. 2006;67:700–706
  15. Britton KT, Lee G, Vale W, Rivier J, Koob GF. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and ‘anxiogenic’ actions of CRF in the rat. Brain Res. 1986;369:303–306
  16. Britton KT, Lee G, Dana R, Risch SC, Koob GF. Activating and ‘anxiogenic’ effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 1986;39:1281–1286
  17. Chabrol H, Ducongé E, Casas C, Roura C, Carey KB. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict. Behav. 2005;30:829–840
  18. Chen Y-C, Holmes A. Effects of topiramate and other anti-glutamatergic drugs on the negative intoxicating actions of ethanol in mice: modulation by genetic strain and stress. Neuropsychopharmacology. 2009;34:1578–1589
  19. Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol. Biochem. Behav. 2007;86:813–821
  20. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983;24:385–396
  21. In:  Collins LM,  Sayer AG editor. New Methods for the Analysis of Change. Washington, DC: American Psychological Association; 2001;
  22. COMBINE Study Group . Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol. Clin. Exp. Res. 2003;27:1107–1122
  23. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005;8:1481–1489
  24. Froehlich J, O'Malley S, Hyytia P, Davidson D, Farren C. Preclinical and clinical studies on naltrexone: what have they taught each other?. Alcohol. Clin. Exp. Res. 2003;27:533–539
  25. Funk CK, O'Dell LE, Crawford EF, Koob GF. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 2006;26:11324–11332
  26. Funk CK, Zorrilla EP, Lee M-J, Rice KC, Koob GF. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry. 2007;61:78–86
  27. Gass JT, Olive MF. Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol. 2008;75:218–265
  28. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J. Neurosci. 2007;27:2718–2726
  29. Geisner IM, Larimer ME, Neighbors C. The relationship among alcohol use, related problems, and symptoms of psychological distress: gender as a moderator in college samples. Addict. Behav. 2004;29:843–848
  30. Gilpin NW, Richardson HN, Koob GF. Effects of CRF-1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 2008;32:1535–1542
  31. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat. Rev. Genet. 2005;6:521–532
  32. Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry. 2008;Epub ahead of print
  33. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, et al. Variation at the rat Crhrl locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc. Natl. Acad. Sci. USA. 2006;103:15236–15241
  34. Hedeker D, Gibbons RD. Longitudinal Data Analysis. New York, NY: Wiley; 2006;
  35. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 2006;111:855–876
  36. Heinz A, Rommelspacher H, Gräf KJ, Kürten I, Otto M, Baumgartner A. Hypothalamic-pituitary-gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: comparison with healthy control subjects. Psychiatry Res. 1995;56:81–95
  37. Junghanns K, Backhaus J, Tietz U, Lange W, Bernzen J, Wetterling T, et al. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol. 2003;38:189–193
  38. Junghanns K, Tietz U, Dibbelt L, Kuether M, Jurth R, Ehrenthal D, et al. Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol. 2005;40:80–85
  39. Keedwell PA, Poon L, Papadopoulos AS, Marshall EJ, Checkley SA. Salivary cortisol measurements during a medically assisted alcohol withdrawal. Addict. Biol. 2001;6:247–256
  40. Kiefer F, Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict. Biol. 2004;9:205–212
  41. Kiefer F, Jahn H, Otte C, Naber D, Wiedemann K. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?. Biol. Psychiatry. 2006;60:74–76
  42. King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, et al. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology. 2002;26:778–788
  43. King AC, Volpicelli JR, Frazer A, O'Brien CP. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl.). 1997;129:15–22
  44. Koob GF. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 2003;27:232–243
  45. Koob GF, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry. 2007;164:1149–1159
  46. Kosten TR, Krystal J. Biological mechanisms in posttraumatic stress disorder. Relevance for substance abuse. Recent Dev. Alcohol. 1988;6:49–68
  47. Krupitsky EM, Rudenko AA, Burakov AM, Slavina TY, Grinenko AA, Pittman B, et al. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol. Clin. Exp. Res. 2007;31:604–611
  48. Lee S, Rivier C. An initial, three-day-long treatment with alcohol induces a long-lasting phenomenon of selective tolerance in the activity of the rat hypothalamic-pituitary-adrenal axis. J. Neurosci. 1997;17:8856–8866
  49. Lee S, Schmidt D, Tilders F, Cole M, Smith A, Rivier C. Prolonged exposure to intermittent alcohol vapors blunts hypothalamic responsiveness to immune and non-immune signals. Alcohol. Clin. Exp. Res. 2000;24:110–122
  50. Lovallo WR, Dickensheets SL, Myers DA, Thomas TL, Nixon SJ. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol. Clin. Exp. Res. 2000;24:651–658
  51. McDevitt-Murphy ME, Weathers FW, Adkins JW. The use of the trauma symptom inventory in the assessment of PTSD. J. Trauma. Stress. 2005;18:63–67
  52. McDevitt-Murphy ME, Weathers FW, Flood AM, Eakin DE, Benson T. The utility of the PAI and the MMPI-2 for discriminating PTSD, depression, and social phobia. Assessment. 2007;14:181–195
  53. Merlo-Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 1995;15:5439–5447
  54. Miller MW, Vogt DS, Mozley SL, Kaloupek DG, Keane TM. PTSD and substance-related problems: the mediating roles of disconstraint and negative emotionality. J. Abnorm. Psychol. 2006;115:369–376
  55. Morey LC. The Personality Assessment Inventory Professional Manual. Odessa, FL: Psychological Assessment Resources; 2006;
  56. Muthén B. Second-generation structural equation modeling with a combination of categorical and continuous latent variables: new opportunities for latent class-latent growth modeling. In:  Collins LM,  Sayer AG editor. New Methods for the Analysis of Change. Washington, DC: American Psychological Association; 2001;p. 289–322
  57. Muthén B, Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics. 1999;55:463–469
  58. Naber D, Pickar D, Davis GC, Cohen RM, Jimerson DC, Elchisak MA, et al. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Psychopharmacology (Berl.). 1981;74:125–128
  59. Newlin DB, Thomson JB. Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychol. Bull. 1990;108:383–402
  60. Norcross, M., Mathur, P., Enoch, A. J., Karlsson, R. M., Brigman, J., Cameron, H. A., et al. (2008). Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl.) 200, 413–424. Erratum (2008). Psychopharmacology (Berl.) 200, 453.
  61. O'Dell LE, Roberts AJ, Smith RT, Koob GF. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol. Clin. Exp. Res. 2004;28:1676–1682
  62. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl.). 2002;160:19–29
  63. Olive MF, Koenig HN, Nannini MA, Hodge CW. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 2002;72:213–220
  64. Olive MF, Mehmert KK, Koenig HN, Camarini R, Kim JA, Nannini MA, et al. A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology (Berl.). 2003;165:181–187
  65. Ouimette P, Read J, Brown PJ. Consistency of retrospective reports of DSM-IV Criterion A traumatic stressors among substance use disorder patients. J. Trauma. Stress. 2005;18:43–51
  66. Overstreet DH, Knapp DJ, Breese GR. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol. Clin. Exp. Res. 2002;26:1259–1268
  67. Overstreet DH, Knapp DJ, Breese GR. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 2004;77:405–413
  68. Palachick B, Chen Y-C, Enoch AJ, Karlsson RM, Mishina M, Holmes A. Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication. Alcohol. Clin. Exp. Res. 2008;32:1479–1492
  69. Rasmussen DD, Boldt BM, Bryant CA, Mitton DR, Larsen SA, Wilkinson CW. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol. Clin. Exp. Res. 2000;24:1836–1849
  70. Rassnick S, Heinrichs SC, Britton KT, Koob GF. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993;605:25–32
  71. Ray, L.A., Capone, C., Sheets, E., Young, D., Chelminski, I., & Zimmerman, M. Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample. Psychiatry Res., in press.
  72. Ray LA, Hutchison KE. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch. Gen. Psychiatry. 2007;64:1069–1077
  73. Ray LA, Mackillop J, Leggio L, Morgan M, Hutchison KE. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacol. Biochem. Behav. 2008;91:489–494
  74. Richardson HN, Lee SY, O'Dell LE, Koob GF, Rivier CL. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal (HPA) axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur. J. Neurosci. 2008;28:1641–1653
  75. Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, et al. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol. Biochem. Behav. 2008;88:497–510
  76. Rimondini R, Arlinde C, Sommer W, Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J. 2002;16:27–35
  77. Roberts AJ, Cole M, Koob GF. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 1996;20:1289–1298
  78. Roberts AJ, Crabbe JC, Keith LD. Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res. 1992;579:296–302
  79. In:  Rose JS,  Chassin L,  Presson CC,  Sherman SJ editor. Multivariate Applications in Substance Use Research. Hillsdale, NJ: Lawrence Erlbaum Associates; 2000;
  80. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology. 2006;189:175–186
  81. Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, et al. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol. Clin. Exp. Res. 1998;22:1430–1436
  82. Schuckit MA. Low level of response to alcohol as a predictor of future alcoholism. Am. J. Psychiatry. 1994;151:184–189
  83. Schulteis G, Markou A, Cole M, Koob GF. Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. U.S.A. 1995;92:5880–5884
  84. Sher L. The role of the hypothalamic-pituitary-adrenal axis dysfunction in the pathophysiology of alcohol misuse and suicidal behavior in adolescents. Int. J. Adolesc. Med. Health. 2007;19:3–9
  85. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, NY: Oxford University Press; 2003;
  86. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl.). 2001;158:343–359
  87. Spanagel R, Kiefer F. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol. Sci. 2008;29:109–115
  88. Stewart SH. Alcohol abuse in individuals exposed to trauma: a critical review. Psychol. Bull. 1996;120:83–112
  89. Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W. Corticotropin-releasing factor produces behavioural activation in rats. Nature. 1982;297:331–333
  90. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H. Naltrexone-induced alterations in human ethanol intoxication. Am. J. Psychiatry. 1994;151:1463–1467
  91. Tabakoff B, Jafee RC, Ritzmann RF. Corticosterone concentrations in mice during ethanol drinking and withdrawal. J. Pharm. Pharmacol. 1978;30:371–374
  92. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 2002;26:1494–1501
  93. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-resuidue ovine hypothalamic peptide that stimulates the secretion of corticotropin and betaendorphin. Science. 1981;213:1394–1397
  94. Walker BM, Koob GF. The γ-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol. Clin. Exp. Res. 2007;31:11–18
  95. Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J. Clin. Endocrinol. Metab. 1991;72:1290–1295
  96. White HR, Labouvie EW. Towards the assessment of adolescent problem drinking. J. Stud. Alcohol. 1989;50:30–37
  97. Zimmerman M. Integrating the assessment methods of researchers in routine clinical practice: the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project. In:  First MB editors. Standardized Evaluation in Clinical Practice. Arlington, NY: American Psychiatric Publishing; 2003;p. 29–74
  98. Zorrilla EP, Valdez GR, Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl.). 2001;158:374–381

PII: S0741-8329(09)00152-9

doi: 10.1016/j.alcohol.2009.06.004

Alcohol
Volume 43, Issue 7 , Pages 499-508 , November 2009

Article Tools